Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Kidney Transplant Recipients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00266123
What this trial is testing

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 420
Large-scale testing (Phase 3)Study completedNCT00248313
What this trial is testing

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Who this might be right for
Kidney Disease
Wyeth is now a wholly owned subsidiary of Pfizer 470
Post-approval studies (Phase 4)Study completedNCT03968588
What this trial is testing

Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Ajou University School of Medicine 108
Large-scale testing (Phase 3)Study completedNCT00238940
What this trial is testing

Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants

Who this might be right for
Renal Transplantation
Novartis 55
Testing effectiveness (Phase 2)Study completedNCT01596062
What this trial is testing

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 16
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Post-approval studies (Phase 4)Study completedNCT00507793
What this trial is testing

Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

Who this might be right for
Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 385
Post-approval studies (Phase 4)Study completedNCT00154232
What this trial is testing

Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Ended earlyNCT00282230
What this trial is testing

Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 150
Testing effectiveness (Phase 2)Study completedNCT02970630
What this trial is testing

Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

Who this might be right for
Kidney Transplantation
Chiesi Farmaceutici S.p.A. 28
Large-scale testing (Phase 3)Study completedNCT00531440
What this trial is testing

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 256
Post-approval studies (Phase 4)Study completedNCT00369161
What this trial is testing

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 228
Post-approval studies (Phase 4)UnknownNCT05872568
What this trial is testing

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Zhishui Chen 270
Post-approval studies (Phase 4)Study completedNCT00634920
What this trial is testing

Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Renal Function
Novartis Pharmaceuticals 204
Post-approval studies (Phase 4)Study completedNCT00240955
What this trial is testing

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Who this might be right for
Renal Transplantation
Novartis 79
Testing effectiveness (Phase 2)Study completedNCT01780844
What this trial is testing

Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Global Development, Inc. 149
Post-approval studies (Phase 4)Study completedNCT00170885
What this trial is testing

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis
Large-scale testing (Phase 3)Study completedNCT00239876
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 140
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Large-scale testing (Phase 3)Ended earlyNCT03995901
What this trial is testing

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Who this might be right for
Transplanted Organ Rejection
Talaris Therapeutics Inc. 15
Next Page